Hosted on MSN15d
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
CNBC's Becky Quick reports on the latest news. Income Tax Reduced For Millions of Americans UMass Found Not Guilty After Student’s $10K Prize Money Gets Rescinded Over Halftime Contest How One ...
MedCity News15d
Vertex Pharma’s Opioid Alternative Wins FDA Approval, First in a New Class of Pain Meds
A novel Vertex Pharmaceuticals drug that takes a new approach to pain is now approved by the FDA, a landmark decision for a first-in-class product that brings patients a treatment alternative ...
BioSpace16d
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
“Today’s approval is a historic milestone for the 80 million people in America who are prescribed a medicine for moderate-to-severe acute pain each year,” said Reshma Kewalramani, M.D., Chief ...
The New York Times26d
Writing Prompts
Would you want to enter your pet in a contest? By The Learning Network Read about the world champions of spreadsheets and about an adult learning how to swim. Then tell us about your own journey ...
The Motley Fool1mon
Should You Buy Vertex Pharmaceuticals Stock Hand Over Fist Before Jan. 30?
What's so special about Jan. 30 for Vertex? It's the PDUFA action date set by the U.S. Food and Drug Administration (FDA) for making an approval decision on suzetrigine in treating acute pain.
Morningstar1mon
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the company’s scheduled webcast from the ...
C&EN1mon
Limiting Halide Exchange and Doping Mn(II) in Vertex-Oriented Cube-Connected Patterned Lead Halide Perovskite Nanorods
School of Materials Sciences, Indian Association for the Cultivation of Science, Kolkata 700032, India ...
Pharmaceutical Technology6mon
Vertex’s blockbuster-in-waiting painkiller suzetrigine set for FDA review next year
Image credit: Shutterstock / JHVEPhoto. The US Food and Drug Administration (FDA) has accepted Vertex Pharmaceuticals’ completed new drug application (NDA) submission for suzetrigine, as the company’s ...